Neurotrophic Factors Used to Treat Spinal Cord Injury

    Research output: Chapter in Book/Conference paperChapterpeer-review

    37 Citations (Scopus)


    The application of neurotrophic factors as a therapy to improve morphological and behavioral outcomes after experimental spinal cord injury (SCI) has been the focus of many studies. These studies vary markedly in the type of neurotrophic factor that is delivered, the mode of administration, and the location, timing, and duration of the treatment. Generally, the majority of studies have had significant success if neurotrophic factors are applied in or close to the lesion site during the acute or the subacute phase after SCI. Comparatively fewer studies have administered neurotrophic factors in order to directly target the somata of injured neurons. The mode of delivery varies between acute injection of recombinant proteins, subacute or chronic delivery using a variety of strategies including osmotic minipumps, cell-mediated delivery, delivery using polymer release vehicles or supporting bridges of some sort, or the use of gene therapy to modify neurons, glial cells, or precursor/stem cells. In this brief review, we summarize the state of play of many of the therapies using these factors, most of which have been undertaken in rodent models of SCI.

    Original languageEnglish
    Title of host publicationVitamins and Hormones
    EditorsGerald Litwack
    Place of PublicationUnited Kingdom
    PublisherAcademic Press
    Number of pages53
    ISBN (Print)9780128122631
    Publication statusPublished - 1 Jan 2017

    Publication series

    NameVitamins and Hormones
    ISSN (Print)0083-6729


    Dive into the research topics of 'Neurotrophic Factors Used to Treat Spinal Cord Injury'. Together they form a unique fingerprint.

    Cite this